Abbott Laboratories (ABT) Shares Outstanding (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Shares Outstanding (Entity) data on file, last reported at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) changed 0.12% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (changed 0.12% YoY), and the FY2025 full-year result was $2.0 billion, changed 0.27% from the prior year.
• Shares Outstanding (Entity) held at $2.0 billion in Q1 2026, from $2.0 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $2.0 billion in Q1 2026 to a low of $2.0 billion in Q1 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) gained 0.06% in 2022 and increased 0.32% in 2025, its largest moves.
• Tracing ABT's Shares Outstanding (Entity) over 5 years: stood at $2.0 billion in 2022, then advanced by 0.07% to $2.0 billion in 2023, then climbed by 0.18% to $2.0 billion in 2024, then gained by 0.27% to $2.0 billion in 2025, then increased by 0.07% to $2.0 billion in 2026.
• Business Quant data shows ABT's Shares Outstanding (Entity) at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.0 billion in Q3 2025.